Home LiteratureArticle Details
PMID: 8726973 Published · ppublish English Journal Article

Inhibition of neuronal cyclin-dependent kinase-5 by staurosporine and purine analogs is independent of activation by Munc-18.

Neurochemical research ·Vol. 21 ·No. 5 ·1996-05-00 ·Pages 629-36

Veeranna, Shetty KT, Amin N, Grant P, Albers RW, Pant HC

Abstract

Neuronal cdk5 can phosphorylate certain lys-ser-pro (KSP) motifs of neurofilaments and tau protein in the nervous system. We have immunoprecipitated the cdk5 from rat brain using a polyclonal antibody raised against the C-terminus of cdk5. The immunoprecipitate has phosphorylated a KSPXK peptide analog of NF-H, as well as histone H1 and a bacterially expressed rat NF-H protein. The kinase activity was inhibited by staurosporine, isopentanyladenine and olomoucine in a dose dependent manner. Kinetic studies indicated Ki values of 39 nM, 38 microM and 8 microM, respectively for staurosporine, isopentanyladenine and olomoucine. The inhibition by staurosporine was non-competitive with respect to phosphoryl acceptor acceptor substrates. Western blot analysis of the immunoprecipitate showed both cdk5 and p67 (Munc-18), a putative regulator molecule of the kinase. Addition of p67 fusion protein enhanced the kinase activity of the immunoprecipitate by 60% above the basal activity. P67 elevated Ki values for both staurosporine and olomoucine. The degree of inhibition at high concentrations of these inhibitors was unaltered by exogenous p67 indicating a lack of competitive interactions with p67. The high affinity of staurosporine for cdk5 suggests that cdk5 may be one of the targets for the neurotropic effect of staurosporine.

MeSH Terms
Amino Acid Sequence Animals Blotting, Western Brain/enzymology Cyclin-Dependent Kinase 5 Cyclin-Dependent Kinases Enzyme Activation Enzyme Inhibitors/pharmacology Female Histones/metabolism Kinetics Male Molecular Sequence Data Neurofilament Proteins/metabolism Neurons/enzymology Oligopeptides Protein Serine-Threonine Kinases/antagonists & inhibitors,metabolism Purines/pharmacology Rats Recombinant Proteins/metabolism Staurosporine/pharmacology Substrate Specificity
Chemicals
Enzyme Inhibitors Histones Neurofilament Proteins Oligopeptides Purines Recombinant Proteins neurofilament protein H Cyclin-Dependent Kinase 5 Protein Serine-Threonine Kinases Cdk5 protein, rat Cyclin-Dependent Kinases Staurosporine
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Veeranna
Laboratory of Neurochemistry, NINDS, NIH, Bethesda, MD, USA 20892-4130, USA.
Shetty K T
Amin N
Grant P
Albers R W
Pant H C
References (43)
43 references, click to expand
  1. Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments.
    J Biol Chem. 1993 Nov 5;268(31):23512-8 PMID: 8226879
  2. Mimicry and inhibition of nerve growth factor effects: interactions of staurosporine, forskolin, and K252a in PC12 cells and normal rat chromaffin cells in vitro.
    J Neurochem. 1990 Oct;55(4):1159-65 PMID: 2118943
  3. Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition.
    Mol Pharmacol. 1992 Jul;42(1):35-43 PMID: 1635552
  4. Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases.
    Trends Pharmacol Sci. 1989 Jun;10(6):218-20 PMID: 2672462
  5. Use and specificity of staurosporine, UCN-01, and calphostin C as protein kinase inhibitors.
    Methods Enzymol. 1991;201:340-7 PMID: 1719345
  6. Molecular characterization of a neuronal-specific protein that stimulates the activity of Cdk5.
    J Neurochem. 1995 May;64(5):1988-95 PMID: 7536802
  7. Purification and characterization of a novel proline-directed protein kinase from bovine brain.
    J Biol Chem. 1992 Jul 5;267(19):13383-90 PMID: 1618840
  8. A new screening test for antimitotic compounds using the universal M phase-specific protein kinase, p34cdc2/cyclin Bcdc13, affinity-immobilized on p13suc1-coated microtitration plates.
    Anticancer Res. 1991 Jul-Aug;11(4):1581-90 PMID: 1660692
  9. Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brain.
    FEBS Lett. 1994 Apr 4;342(2):203-8 PMID: 8143878
  10. Staurosporine both activates and inhibits serine/threonine kinases in human platelets.
    Biochem J. 1991 Apr 15;275 ( Pt 2):301-6 PMID: 1827254
  11. cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterization.
    Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6844-8 PMID: 8341707
  12. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells.
    Cell. 1992 Feb 7;68(3):451-63 PMID: 1371237
  13. The nerve growth factor 35 years later.
    Science. 1987 Sep 4;237(4819):1154-62 PMID: 3306916
  14. Characterization of receptor tyrosine-specific protein kinases by the use of inhibitors. Staurosporine is a 100-times more potent inhibitor of insulin receptor than IGF-I receptor.
    Biochem Biophys Res Commun. 1988 Dec 30;157(3):955-62 PMID: 2974700
  15. A polymer-dependent increase in phosphorylation of beta-tubulin accompanies differentiation of a mouse neuroblastoma cell line.
    J Cell Biol. 1985 Mar;100(3):764-74 PMID: 2857724
  16. Two-stage expression of neurofilament polypeptides during rat neurogenesis with early establishment of adult phosphorylation patterns.
    J Neurosci. 1987 Nov;7(11):3489-504 PMID: 3119790
  17. Staurosporine inhibits tyrosine-specific protein kinase activity of Rous sarcoma virus transforming protein p60.
    J Antibiot (Tokyo). 1987 May;40(5):706-8 PMID: 3038816
  18. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.
    Cell. 1994 Nov 18;79(4):573-82 PMID: 7954824
  19. NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1.
    J Neurosci. 1995 Sep;15(9):6200-12 PMID: 7666202
  20. Dephosphorylation-induced interactions of neurofilaments with microtubules.
    J Biol Chem. 1990 Dec 15;265(35):21852-8 PMID: 2254337
  21. Selectivity of protein kinase inhibitors in human intact platelets.
    Cell Signal. 1990;2(4):329-38 PMID: 2252838
  22. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system.
    Development. 1993 Dec;119(4):1029-40 PMID: 8306873
  23. Regulation of the differentiation of PC12 pheochromocytoma cells.
    Environ Health Perspect. 1989 Mar;80:127-42 PMID: 2647474
  24. Inhibition of the cellular actions of nerve growth factor by staurosporine and K252A results from the attenuation of the activity of the trk tyrosine kinase.
    Biochemistry. 1992 Apr 28;31(16):4034-9 PMID: 1314657
  25. Selective activation of p42 mitogen-activated protein (MAP) kinase in murine B lymphoma cell lines by membrane immunoglobulin cross-linking. Evidence for protein kinase C-independent and -dependent mechanisms of activation.
    Biochem J. 1992 Oct 1;287 ( Pt 1):269-76 PMID: 1384467
  26. Staurosporine: an effective inhibitor for Ca2+/calmodulin-dependent protein kinase II.
    J Neurochem. 1991 Jan;56(1):294-8 PMID: 1846174
  27. Neuronal cdc2-like kinase.
    Trends Biochem Sci. 1995 Jan;20(1):33-7 PMID: 7878742
  28. Differential inhibition of cytosolic and membrane-derived protein kinase C activity by staurosporine and other kinase inhibitors.
    FEBS Lett. 1995 Apr 3;362(2):139-42 PMID: 7536688
  29. Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine.
    FEBS Lett. 1994 Jan 24;338(1):85-8 PMID: 8307162
  30. A brain-specific activator of cyclin-dependent kinase 5.
    Nature. 1994 Sep 29;371(6496):423-6 PMID: 8090222
  31. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.
    Proc Natl Acad Sci U S A. 1976 Jul;73(7):2424-8 PMID: 1065897
  32. Blockage of nerve growth factor action in PC12h cells by staurosporine, a potent protein kinase inhibitor.
    J Neurochem. 1989 Dec;53(6):1675-85 PMID: 2553861
  33. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5.
    Nature. 1994 Sep 29;371(6496):419-23 PMID: 8090221
  34. Inhibition of cyclin-dependent kinases by purine analogues.
    Eur J Biochem. 1994 Sep 1;224(2):771-86 PMID: 7925396
  35. Staurosporine induces tyrosine phosphorylation of a 145 kDa protein but does not activate gp140trk in PC12 cells.
    Eur J Pharmacol. 1994 Oct 14;269(2):255-64 PMID: 7851502
  36. Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases.
    Biochem Biophys Res Commun. 1992 Apr 15;184(1):80-5 PMID: 1567459
  37. Evidence for cdk5 as a major activity phosphorylating tau protein in porcine brain extract.
    J Biochem. 1995 Apr;117(4):741-9 PMID: 7592534
  38. Neurites induced by staurosporine in PC12 cells are resistant to colchicine and express high levels of tau proteins.
    Mol Pharmacol. 1994 Jan;45(1):29-35 PMID: 8302277
  39. Principles of CDK regulation.
    Nature. 1995 Mar 9;374(6518):131-4 PMID: 7877684
  40. Effects of staurosporine on protein kinase C and amylase secretion from pancreatic acini.
    Am J Physiol. 1989 Oct;257(4 Pt 1):G548-53 PMID: 2478031
  41. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle.
    Cell. 1994 Oct 21;79(2):181-4 PMID: 7954786
  42. Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase.
    Biochem Biophys Res Commun. 1986 Mar 13;135(2):397-402 PMID: 3457562
  43. Staurosporine activates a 60,000 M(r) protein kinase in bovine chromaffin cells that phosphorylates myelin basic protein in vitro.
    J Neurochem. 1993 Aug;61(2):697-703 PMID: 7687659
Article Info
Journal
Neurochemical research
Abbr.
Neurochem Res
ISSN
0364-3190
Published
1996-05-00
Pages
629-36
Language
English
Region
United States
NLM ID
7613461
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com